Stempeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.4M

  • Investors
  • 5

Stempeutics General Information

Description

Developer of a stem-cell platform designed to develop and commercialize novel therapeutics based on adult stem cells. The company's platform builds an IP portfolio and is proactively engaged in extensive research in the area of stem cell technology and its application, enabling healthcare professionals to have stem cell products that address the major unmet medical needs of a patient.

Contact Information

Website
www.stempeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Manipal Hospitals Whitefield Number 143
  • EPIP Industrial Area, ITPL Main Road, Whitefield
  • Bangalore, Karnataka 560048
  • India
+91 080
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • 3rd Floor, Manipal Hospitals Whitefield Number 143
  • EPIP Industrial Area, ITPL Main Road, Whitefield
  • Bangalore, Karnataka 560048
  • India
+91 080

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stempeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 07-Sep-2022 $6.4M Completed Generating Revenue
8. Later Stage VC 24-Jul-2019 Completed Generating Revenue
7. Later Stage VC 04-Jul-2016 Completed Generating Revenue
6. Merger/Acquisition 15-Oct-2015 Cancelled Generating Revenue
5. Later Stage VC 09-Mar-2015 Completed Generating Revenue
4. Later Stage VC 10-Jul-2014 Completed Generating Revenue
3. Grant 11-Nov-2011 Completed Generating Revenue
2. Early Stage VC 01-Jun-2009 $10M $10M Completed Startup
1. Joint Venture Completed Startup
To view Stempeutics’s complete valuation and funding history, request access »

Stempeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Stempeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Stempeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a stem-cell platform designed to develop and commercialize novel therapeutics based on adult stem cells. Th
Drug Discovery
Bangalore, India
49 As of 2024

Saratoga, CA
 

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stempeutics Competitors (4)

One of Stempeutics’s 4 competitors is Bugworks Research, a Venture Capital-Backed company based in Saratoga, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bugworks Research Venture Capital-Backed Saratoga, CA
Biocon Formerly PE-Backed Bengaluru, India
Immuneel Venture Capital-Backed Bengaluru, India
ImmunoACT Venture Capital-Backed Navi Mumbai, India
To view Stempeutics’s complete competitors history, request access »

Stempeutics Patents

  • 59

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Stempeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240189359-A1 Combination therapy comprising a composition of mesenchymal stromal cells and hyaluronic acid for use in treatment of osteoarthritis Pending 07-Dec-2022
AU-2022488470-A1 Combination therapy comprising a composition of mesenchymal stromal cells and hyaluronic acid for use in treatment of osteoarthritis Pending 07-Dec-2022
CA-2878299-A1 Methods of upscaling mesenchymal stromal cell production, compositions and kit thereof Inactive 24-Jun-2014
JP-2016007214-A Method to scale up mesenchymal interstitial cell production, composition thereof and a kit Pending 24-Jun-2014
EP-2960329-A1 Methods of upscaling mesenchymal stromal cell production, compositions and kit thereof Inactive 24-Jun-2014 C12N5/0663
To view Stempeutics’s complete patent history, request access »

Stempeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stempeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kemwell Biopharma Corporation Minority
Department of Biotechnology Government
Cipla New Ventures Impact Investing Minority
Cipla Corporation Majority
Manipal Education and Medical Group Corporation Majority
To view Stempeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Stempeutics FAQs

  • When was Stempeutics founded?

    Stempeutics was founded in 2006.

  • Where is Stempeutics headquartered?

    Stempeutics is headquartered in Bangalore, India.

  • What is the size of Stempeutics?

    Stempeutics has 49 total employees.

  • What industry is Stempeutics in?

    Stempeutics’s primary industry is Drug Discovery.

  • Is Stempeutics a private or public company?

    Stempeutics is a Private company.

  • What is the current valuation of Stempeutics?

    The current valuation of Stempeutics is .

  • What is Stempeutics’s current revenue?

    The current revenue for Stempeutics is .

  • How much funding has Stempeutics raised over time?

    Stempeutics has raised $33.4M.

  • Who are Stempeutics’s investors?

    Kemwell Biopharma, Department of Biotechnology, Cipla New Ventures, Cipla, and Manipal Education and Medical Group have invested in Stempeutics.

  • Who are Stempeutics’s competitors?

    Bugworks Research, Biocon, Immuneel, and ImmunoACT are competitors of Stempeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »